• No results found

PERIPHERAL DISORDERS

In document Dit 2014 Step 2 Ck-1 (Page 38-43)

3 Question Warm-Up

1. H o w do the features o f acute dystonia differ from tardive dyskinesia?

2. W h ich medication is used more than any other in the treatm ent o f Parkinson patients?

3. W h a t is the m axim um am ount o f tim e a TLA. may last?

4. W hat is the classic presentation of Guillain-Barre syndrome (GBS)?

° Symmetric muscle weakness that progresses over days to 4 weeks (usually 2 weeks) Usually beginning in the distal legs but may begin in the arms or facial muscles in 10% of cases

__________________________ requiring mechanical ventilation in ___________of cases

__________________________ and/or oropharyngeal weakness in __________ which may include bilateral facial muscle paralysis

° Autonomic dysfunction in 70% - usually________________________

° Absent or depressed deep tendon reflexes

° Little if any change in sensation

° No fever at the onset of symptoms

° GBS may be preceded by:

Campylobacter jejuni diarrheal illness (about 20% of cases) HIV infection

5. How is the diagnosis of Guillain-Barre syndrome made in a patient with ascending muscle paralysis?

° Characteristic clinical presentation

° CSF analysis (elevated protein and normal WBCs)

° Electrodiagnostic studies: nerve conduction studies and electromyography (EMG) reveal

PERIPHERAL DISORDERS 6. W hat is the prognosis of a patient with Guillain-Barre syndrome?

° Spontaneous regression and complete recovery by 1 year in 80-90%

° Relapse in 10%

° Prolonged disease with delayed or incomplete recovery in 5-10%

° Death despite ICU care in 5%

7. W hat is the treatment of Guillain-Barre syndrome?

° Hospitalization for respiratory monitoring including vital capacity, BP monitoring, cardiac monitoring (telemetry) and daily abdominal auscultation for ileus

° Mechanical ventilation required in 30% of patients

° ICU monitoring for autonomic dysfunction required in 20% of patients Equally effective at shortening time to independent walking by iSQfb Combining the two offers no additional benefit

° _______________________ are N O T recommended in the treatment of GBS.

Previously the mainstay of therapy; new studies show absolutely no benefit.

8. W hat is required to make the diagnosis of Bell’s palsy?

Clinical diagnosis:

° Diffuse involvement of the entire facial nerve —> facial muscle paralysis (upper and lower) Rule out Lyme disease b y _________________ : tick bite, heart block, arthritis, vertigo, hearing loss

Rule out Otitis media b y__________________

Rule out stroke b y _______________________

° Acute onset (1-2 days) —> progressively worsening weakness for 3 weeks —» recovery within 6 months

° Anything other than the above presentation requires imaging (CT and/or M RI) and screening blood tests to rule out other pathology

| 2 4]

W hat is the treatm ent for Bell’s palsy?

° Eye care to prevent corneal trauma Artificial tears hourly while awake Lubricating ointment qHS Patch covering the eye at night

° Glucocorticoids (e.g., prednisone 60mg daily x 1 week)

° +/- Valacyclovir lOOOmg tid x 1 week (acyclovir provides no additional benefit over glucocorticoids)

End of Session Quiz

10. W h a t test can help m ake the diagnosis o f myasthenia gravis?

11. H o w does Lam bert-Eaton syndrome differ from myasthenia gravis (M G ) on history and physical exam?

12. W h a t are the treatm ent options for benign essential tremor?

13. A 35-year-old w om an presents w ith ptosis and diplopia that worsens throughout the day. W h a t is the underlying problem?

14. W h a t is a classic presentation o f Guillain-Barre syndrome?

15. H o w do you treat Guillain-Barre syndrome?

16. H o w can Bell’s palsy be easily differentiated from a m otor cortex stroke?

NEOPLASMS AND SLEEP

s ' . i ■ • - v ... '■ mw® ® " m " $

3 Question Warm-Up

1 W h a t two medications could be used for prophylaxis against meningococcal meningitis?

2. W h a t two classes o f medication could be used both to treat chronic hypertension and also to prevent recurrent migraines?

3. H ow do edrophonium, neostigmine and pyridostigmine work in the treatment o f myasthenia gravis?

. W hat are the differences between nightmares and night terrors?

° Nightmares - during REM sleep, patients that appear to wake up are actually awake

° Night terrors - during non-REM sleep, patients that appear awake (and are frightened/

screaming, tachycardic and diaphoretic) are actually not fully awake, difficult to arouse and usually fall right back to sleep after the episode

W hat is required to make the diagnosis of narcolepsy?

° _______________________ (sudden loss of muscle tone) only occurs in narcolepsy and is virtually diagnostic when present

° Other causes of excessive daytime sleepiness are ruled out

Overnight polysomnogram (to r/o O SA and periodic limb movement disorder) Rule out sedating medications as a cause

° Multiple Sleep Latency Test - when given 4-5 opportunities to nap every 2 hours, narcolepsy patients fall asleep in less than 8 minutes

W hat is the treatm ent for narcolepsy?

° Avoidance of drugs that cause sleepiness

° Scheduled naps (once or twice a day for 10-20 minutes)

° Stimulants - _______________________ is first-line

° Support group attendance

° I f cataplexy —* venlafaxine, fluoxetine or atomoxetine

W hat medications are common in the treatm ent of insomnia? W hat makes each one unique?

M elatonin Non-addictive, O T C , vivid dreams, safe for < 3 months Valerian O T C herbal remedy, studies show no benefit

A ntihistam ines (diphenhydramine, doxylamine)

Commonly used by patients first-line, associated with poor sleep quality, not for long-term use, anticholinergic side effects (avoid in the elderly)

Trazodone Antidepressant, decreases sleep latency, small risk of priapism

TC A s

(amitriptyline, doxepin)

Antidepressant, small risk of arrhythmias (obtain EKG prior to use), anticholinergic side effects (avoid in the elderly)

Addictive, short-term only (< 35 days)

Zolpidem Zaleplon

Act at the benzo receptor, short-term only (< 35 days), rebound insomnia when discontinued

Eszopiclone May be used long-term

Ramelteon Non-addictive because it works at melatonin receptors instead of G A B A /benzo receptors, avoid if hepatic insufficiency, long-term studies are lacking

NEOPLASMS ANDSLEEP 8. Restless Leg Syndrome

° The sensation of unpleasant paresthesias that compels the patient to have voluntary, spontaneous, continuous leg movements that temporarily relieve the sensations. The discomfort worsens at rest, in the evening and/or during sleep. Sensation of “spiders or ants” on/in K et/calf muscles.

° Usually a primary, idiopathic disorder

° Secondary RLS can result from iron deficiency, end-stage renal disease, diabetic neuropathy, Parkinson disease, pregnancy, rheumatic diseases (RA), varicose veins, caffeine intake.

° Treatment: pramipexole or ropinirole qHS (or levodopa/carbidopa), iron replacement, avoidance of caffeine, clonazepam qHS, gabapentin, opioids

In document Dit 2014 Step 2 Ck-1 (Page 38-43)

Related documents